4 edition of Biomarkers in kidney disease found in the catalog.
A biomarker is a molecule that is measured as a marker of normal biological processes, disease processes or the response to a diagnostic or therapeutic intervention. Kidney diseases like acute kidney injury, chronic kidney disease, diabetic nephropathy, glomerular disease, renal cancer and preeclampsia still have a high morbidity. Measurement of biomarkers in the blood or urine that detect patients at risk of kidney diseases or that detect kidney diseases in the earliest stage may ultimately result in preventative or earlier or more effective treatments for kidney diseases. Biomarkers of Kidney Disease reviews the basic and clinical research on biomarkers of the common kidney diseases including acute kidney injury, chronic kidney disease, renal cancer, diabetic nephropathy, glomerular disease and preeclampsia. The characteristics of an ideal biomarker of kidney diseases and statistical analysis of biomarker studies is detailed. The latest techniques for biomarker detection like metabolomics and proteomics is covered in the book. This comprehensive book details the latest advances made in the field of biomarker research and development in kidney diseases. The book is an ideal companion for those interested in biomarker research and development, proteomics and metabolomics, kidney diseases, statistical analysis, transplantation and preeclampsia. * Presents a comprehensive, translational source for all aspects of renal biomarkers in one reference work * Experts in renal disease biomarkers (from all areas of academic and medical research) take readers from the bench research (cellular and molecular mechanism) to new therapeutic approaches.
Electronic reproduction. Amsterdam : Elsevier Science & Technology, 2010. Mode of access: World Wide Web. System requirements: Web browser. Title from title screen (viewed on Sep. 27, 2010). Access may be restricted to users at subscribing institutions.
|Statement||edited by Charles L. Edelstein|
|Contributions||ScienceDirect (Online service)|
|LC Classifications||RC903.9 .B56 2010|
|The Physical Object|
|Format||[electronic resource] /|
Get this from a library! Biomarkers in kidney disease. [Vinood B Patel; Victor R Preedy;] -- In the past decade there has been a major sea change in the way disease is diagnosed and investigated due to the advent of high throughput technologies, such as microarrays, lab on a chip, The discovery of metabolomics-based biomarkers has been a focus of recent kidney dysfunction research. In the present study, we aimed to identify metabolites associated with chronic kidney disease (CKD) in the general population using a cross-sectional study design. At
Biomarkers of Kidney Disease by Charles L. Edelstein, , available at Book Depository with free delivery :// Diabetic kidney disease (DKD) remains one of the leading causes of premature death in diabetes. DKD is classified on albuminuria and reduced kidney function (estimated glomerular filtration rate (eGFR)) but these have modest value for predicting future renal status. There is an unmet need for biomarkers that can be used in clinical settings which also improve prediction of renal decline on top
In this new book edited by Charles Edelstein, experts present the state of the art information on the current development and use of biomarkers for a wide range of kidney diseases, including acute kidney injury, glomerulonephritis and nephrotic syndrome, chronic kidney disease, and :// Chronic Kidney Disease, Progression and Biomarkers Clinical Study Group Chronic kidney disease (CKD) describes a wide variety of kidney disorders that cause damage to the kidneys over a period of months or years. It is relatively common, affecting more than 10 per cent of adults in most countries where studies have been done. In addition
pageant of the Mayflower and the Pilgrim fathers.
The 2007-2012 Outlook for Room Air Conditioners with 15,000 to 16,999 BTU Per Hour in the United States
Second year practical classes in undergraduate chemistry courses in England and Wales
Ethiopian constitutional and legal development
Alkali Soil of Desert Area - with 60 Figures and 16 Plates
The pageant of the New World
Mystic Path to Cosmic Power
Plato and the city
Cedar Fort quadrangle, Utah--Utah Co
Halliwells Film guide
evaluation of the Khalsa-Diwan Moberly Educational Program (Under the mango tree) Vancouver, summer 1971
Transforming government for the 21st century
Biomarkers of Kidney Disease, Second Edition, focuses on the basic and clinical research of biomarkers in common kidney diseases, detailing the characteristics of an ideal biomarker. The latest techniques for biomarker detection, including metabolomics and proteomics are covered in the :// Kidney diseases like acute kidney injury, chronic kidney disease, diabetic nephropathy, glomerular disease, renal cancer and preeclampsia still have a high morbidity.
Measurement of biomarkers in the blood or urine that detect patients at risk of kidney diseases or that detect kidney diseases in the earliest stage may ultimately result in Biomarkers in Kidney Disease embraces a holistic approach by combining information on different conditions that affect the kidney and the use of biomarkers.
Biomarkers are described in terms of conventional, new and emerging analytes, techniques, platforms and applications. It covers the latest knowledge and :// There is thus a demand for a comprehensive and focused evidenced-based text and scientific literature that addresses these issues.
Hence the formulation of Biomarkers in Disease. The series covers a wide number of areas including for example, nutrition, cancer, endocrinology, cardiology, addictions, immunology, birth defects, genetics, and so :// In this new book edited by Charles Edelstein, experts present the state of the art information on the current development and use of biomarkers for a wide range of kidney diseases, including acute kidney injury, glomerulonephritis and nephrotic syndrome, chronic kidney disease, and preeclampsia.
I found this book well written and informative › Books › New, Used & Rental Textbooks › Medicine & Health Sciences. In this new book edited by Charles Edelstein, experts present the state of the art information on the current development and use of biomarkers for a wide range of kidney diseases, including acute kidney injury, glomerulonephritis and nephrotic syndrome, chronic kidney disease, and preeclampsia.
I found this book well written and informative › Books › Medical Books › Medicine. Description: This book's focus on biomarkers of kidney disease is particularly important because, despite recent advances in the discovery of these diagnostic and prognostic biomarkers using metabolomics and proteomics, there is a paucity of successful implementation in routine clinical :// Introduction.
Diabetic kidney disease (DKD) and its most severe manifestation, end-stage renal disease (ESRD), remains one of the leading causes of reduced lifespan in people with diabetes .Even early stages of DKD confer a substantial increase in the risk of cardiovascular disease (CVD) [1, 2], so the therapeutic goal should be to prevent these earlier stages, not just :// The book is an ideal companion for those interested in biomarker research and development, proteomics and metabolomics, kidney diseases, statistical analysis, transplantation, and preeclampsia.
New chapters include biomarkers of cardiovascular disease in patients with CKD, biomarkers of Polycystic Kidney Disease, and biomarkers and the role of Diabetic kidney disease (DKD) remains one of the leading causes of reduced lifespan in diabetes.
The quest for both prognostic and surrogate endpoint biomarkers for advanced DKD and end-stage renal disease has received major investment and interest in recent :// Biomarkers in Kidney Disease Content In some countries such as the United States, kidney disease kills more people than cancers of the prostate or breast.
In the United States for example there are over 15 million individuals with kidney disease. Translated to a worldwide basis, kidney disease of various aetiologies represent a significant burden Hello Select your address Best Sellers Today's Deals New Releases Books Electronics Gift Ideas Customer Service Home Computers Today's Deals New Releases Books Electronics Gift Ideas Customer Service Home Computers 2 days ago In conclusion, over the last decade there has been intense interest in finding and qualifying new biomarkers of kidney injury.
Biomarkers will enable us to diagnose kidney injury earlier and provide better information about the status of ongoing injury in patients with CKD as well as predict the likelihood of progression of :// Biomarkers in Kidney Disease PDF Biomarkers in Kidney Disease PDF Free Download, Biomarkers in Kidney Disease PDF, Biomarkers in Kidney Disease Ebook Content In some countries such as the United States, kidney disease kills more people than cancers of the prostate or breast.
In the United States for example there are over 15 million Purpose of the review: Acute kidney injury (AKI) and chronic kidney disease (CKD) are conditions that substantially increase morbidity and mortality.
Although novel biomarkers are being used in practice, the diagnosis of AKI and CKD is still made with surrogate markers of GFR, such as serum creatinine (SCr), urine output and creatinine based estimating :// Patients with chronic kidney disease (CKD) are at a particularly high risk for cardiovascular disease.
Vascular calcification (VC) is considered a cardiovascular risk marker, so in CKD patients screening for the presence of VC is suggested in current guidelines. VC is the result of both passive and Since laboratory testing and biomarkers are an integral part in the diagnosis and treatment of kidney disease, Kidney Biomarkers: Clinical Aspects and Laboratory Determination covers currently used biomarkers as well as markers that are in development.
Laboratories are increasingly more involved in the follow-up confirmatory laboratory testing and this unique volume showcases the collaboration Keywords:Cardiovascular events, chronic kidney disease, C-reactive protein, hemodialysis, inflammatory biomarkers, interleukins, TWEAK.
Abstract:Interest in the association between inflammation and chronic kidney disease (CKD) is increasing. During the last 20 years, classical markers have shown an important association between inflammation and ?tracking-code=4. Biomarkers in chronic kidney disease: a review Robert G.
Fassett 1,2,3, Sree K. Venuthurupalli 3,4, Glenda C. Gobe 3, Jeff S. Coombes 2, Matthew A. Cooper 5 and Wendy E. Hoy 3(15)/pdf. Title:Inflammatory Biomarkers in Chronic Kidney Disease: A Review VOLUME: 2 ISSUE: 2 Author(s):Borja Quiroga, Carmela Marin, Marian Goicoechea, Javier Reque and Jose Luno Affiliation:Nephrology Unit, Hospital General Universitario Gregorio Maranon, C/Doctor Esquerdo, 46, Madrid, Spain.
Keywords:Cardiovascular events, chronic kidney disease, C-reactive protein. The current unidimensional paradigm of kidney disease detection is incompatible with the complexity and heterogeneity of renal pathology.
The diagnosis of kidney disease has largely focused on glomerular filtration, while assessment of kidney tubular health has notably been absent. Following insult, the kidney tubular cells undergo a cascade of cellular responses that result in the production KW - chronic kidney disease.
KW - intensive care. KW - sepsis. KW - urinary oxygen tension. U2 - /_ DO - /_ M3 - Chapter (Book) SN - SN - T3 - Biomarkers in Disease. SP - EP - BT - Biomarkers in Kidney Disease. A2 - Patel, Vinood B. A2 - Preedy, Victor ://Currently available biomarkers for the detection and prognosis of kidney disease offer an imperfect indication of kidney function, and are not useful across all types of kidney disease.